Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
<iframe src="https://statesidedaily.com/embed/cluster/5214762fd7a57fbf8a8660fb38441a6d33ae20e2" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists"></iframe>
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
